세계의 정맥 스텐트 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)

Venous Stents Market - Scope of Report

TMR's report on the global Venous Stents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global Venous Stents market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Venous Stents market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Venous Stents market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Venous Stents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Venous Stents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Venous Stents market.

The report delves into the competitive landscape of the global Venous Stents market. Key players operating in the global Venous Stents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Venous Stents market profiled in this report.

Key Questions Answered in Global Venous Stents Market Report:

• What is the sales/revenue generated by Venous Stents across all regions during the forecast period?
• What are the opportunities in the global Venous Stents market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Venous Stents Market - Research Objectives and Research Approach

The comprehensive report on the global Venous Stents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Venous Stents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Venous Stents market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Venous Stents Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Venous Stents Market Analysis and Forecasts, 2020-2034
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. Epidemiology of Venous Diseases
• 5.2. Product Mapping: Venous Stents
• 5.3. Clinical Trial Analysis
• 5.4. Regulatory Landscape for Venous Stents in Key Regions / Countries
• 5.5. Key Industry Events (Partnerships, Collaborations, Product approvals, Mergers and Acquisitions, Funding and investments)
• 5.6. Impact of COVID-19 Pandemic

6. Global Venous Stents Market Analysis and Forecasts, By Technology

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Stent Design, 2020-2034
  • 6.3.1. Iliac Vein Stent Technology
  • 6.3.2. Wallstent Technology
  • 6.3.3. Others
• 6.4. Market Attractiveness By Technology

7. Global Venous Stents Market Analysis and Forecasts, By Material

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Material, 2020-2034
  • 7.3.1. Nitinol
  • 7.3.2. Elgiloy
  • 7.3.3. Stainless Steel
• 7.4. Market Attractiveness By Material

8. Global Venous Stents Market Analysis and Forecasts, By Stent Design

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Stent Design, 2020-2034
  • 8.3.1. Braided
  • 8.3.2. Laser-cut
  • 8.3.3. Open-cell
  • 8.3.4. Closed-cell
• 8.4. Market Attractiveness By Stent Design

9. Global Venous Stents Market Analysis and Forecasts, By Placement of Stent

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast By Placement of Stent, 2020-2034
  • 9.3.1. Lower Limbs
  • 9.3.2. Thorax
  • 9.3.3. Abdomen
  • 9.3.4. Upper Limbs
• 9.4. Market Attractiveness By Placement of Stent

10. Global Venous Stents Market Analysis and Forecasts, By Indication

• 10.1. Introduction & Definition
• 10.2. Key Findings / Developments
• 10.3. Market Value Forecast By Indication, 2020-2034
  • 10.3.1. Chronic Deep Vein Thrombosis
  • 10.3.2. Post Thrombotic Syndrome
  • 10.3.3. May-Thurner Syndrome
  • 10.3.4. Nutcracker Syndrome
  • 10.3.5. Hemodialysis / Arteriovenous Fistulae
  • 10.3.6. Others
• 10.4. Market Attractiveness By Indication

11. Global Venous Stents Market Analysis and Forecasts, By End-user

• 11.1. Introduction & Definition
• 11.2. Key Findings / Developments
• 11.3. Market Value Forecast By End-user, 2020-2034
  • 11.3.1. Hospitals
  • 11.3.2. Ambulatory Surgical Centers
  • 11.3.3. Specialty Centers
  • 11.3.4. Others
• 11.4. Market Attractiveness By End-user

12. Global Venous Stents Market Analysis and Forecasts, By Region

• 12.1. Key Findings
• 12.2. Market Value Forecast By Region
  • 12.2.1. North America
  • 12.2.2. Europe
  • 12.2.3. Asia Pacific
  • 12.2.4. Latin America
  • 12.2.5. Middle East & Africa
• 12.3. Market Attractiveness By Region

13. North America Venous Stents Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Technology, 2020-2034
  • 13.2.1. Iliac Vein Stent Technology
  • 13.2.2. Wallstent Technology
  • 13.2.3. Others
• 13.3. Market Value Forecast By Material, 2020-2034
  • 13.3.1. Nitinol
  • 13.3.2. Elgiloy
  • 13.3.3. Stainless Steel
• 13.4. Market Value Forecast By Stent Design, 2020-2034
  • 13.4.1. Braided
  • 13.4.2. Laser-cut
  • 13.4.3. Open-cell
  • 13.4.4. Closed-cell
• 13.5. Market Value Forecast By Placement of Stent, 2020-2034
  • 13.5.1. Lower Limbs
  • 13.5.2. Thorax
  • 13.5.3. Abdomen
  • 13.5.4. Upper Limbs
• 13.6. Market Value Forecast By Indication, 2020-2034
  • 13.6.1. Chronic Deep Vein Thrombosis
  • 13.6.2. Post Thrombotic Syndrome
  • 13.6.3. May-Thurner Syndrome
  • 13.6.4. Nutcracker Syndrome
  • 13.6.5. Hemodialysis / Arteriovenous Fistulae
  • 13.6.6. Others
• 13.7. Market Value Forecast By End-user, 2020-2034
  • 13.7.1. Hospitals
  • 13.7.2. Ambulatory Surgical Centers
  • 13.7.3. Specialty Centers
  • 13.7.4. Others
• 13.8. Market Value Forecast By Country, 2020-2034
  • 13.8.1. U.S.
  • 13.8.2. Canada
• 13.9. Market Attractiveness Analysis
  • 13.9.1. By Technology
  • 13.9.2. By Material
  • 13.9.3. By Stent Design
  • 13.9.4. By Placement of Stent
  • 13.9.5. By Indication
  • 13.9.6. By End-user
  • 13.9.7. By Country

14. Europe Venous Stents Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Technology, 2020-2034
  • 14.2.1. Iliac Vein Stent Technology
  • 14.2.2. Wallstent Technology
  • 14.2.3. Others
• 14.3. Market Value Forecast By Material, 2020-2034
  • 14.3.1. Nitinol
  • 14.3.2. Elgiloy
  • 14.3.3. Stainless Steel
• 14.4. Market Value Forecast By Stent Design, 2020-2034
  • 14.4.1. Braided
  • 14.4.2. Laser-cut
  • 14.4.3. Open-cell
  • 14.4.4. Closed-cell
• 14.5. Market Value Forecast By Placement of Stent, 2020-2034
  • 14.5.1. Lower Limbs
  • 14.5.2. Thorax
  • 14.5.3. Abdomen
  • 14.5.4. Upper Limbs
• 14.6. Market Value Forecast By Indication, 2020-2034
  • 14.6.1. Chronic Deep Vein Thrombosis
  • 14.6.2. Post Thrombotic Syndrome
  • 14.6.3. May-Thurner Syndrome
  • 14.6.4. Nutcracker Syndrome
  • 14.6.5. Hemodialysis / Arteriovenous Fistulae
  • 14.6.6. Others
• 14.7. Market Value Forecast By End-user, 2020-2034
  • 14.7.1. Hospitals
  • 14.7.2. Ambulatory Surgical Centers
  • 14.7.3. Specialty Centers
  • 14.7.4. Others
• 14.8. Market Value Forecast By Country / Sub-region, 2020-2034
  • 14.8.1. Germany
  • 14.8.2. U.K.
  • 14.8.3. France
  • 14.8.4. Spain
  • 14.8.5. Italy
  • 14.8.6. Rest of Europe
• 14.9. Market Attractiveness Analysis
  • 14.9.1. By Technology
  • 14.9.2. By Material
  • 14.9.3. By Stent Design
  • 14.9.4. By Placement of Stent
  • 14.9.5. By Indication
  • 14.9.6. By End-user
  • 14.9.7. By Country / Sub-region

15. Asia Pacific Venous Stents Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast By Technology, 2020-2034
  • 15.2.1. Iliac Vein Stent Technology
  • 15.2.2. Wallstent Technology
  • 15.2.3. Others
• 15.3. Market Value Forecast By Material, 2020-2034
  • 15.3.1. Nitinol
  • 15.3.2. Elgiloy
  • 15.3.3. Stainless Steel
• 15.4. Market Value Forecast By Stent Design, 2020-2034
  • 15.4.1. Braided
  • 15.4.2. Laser-cut
  • 15.4.3. Open-cell
  • 15.4.4. Closed-cell
• 15.5. Market Value Forecast By Placement of Stent, 2020-2034
  • 15.5.1. Lower Limbs
  • 15.5.2. Thorax
  • 15.5.3. Abdomen
  • 15.5.4. Upper Limbs
• 15.6. Market Value Forecast By Indication, 2020-2034
  • 15.6.1. Chronic Deep Vein Thrombosis
  • 15.6.2. Post Thrombotic Syndrome
  • 15.6.3. May-Thurner Syndrome
  • 15.6.4. Nutcracker Syndrome
  • 15.6.5. Hemodialysis / Arteriovenous Fistulae
  • 15.6.6. Others
• 15.7. Market Value Forecast By End-user, 2020-2034
  • 15.7.1. Hospitals
  • 15.7.2. Ambulatory Surgical Centers
  • 15.7.3. Specialty Centers
  • 15.7.4. Others
• 15.8. Market Value Forecast By Country / Sub-region, 2020-2034
  • 15.8.1. China
  • 15.8.2. Japan
  • 15.8.3. India
  • 15.8.4. Australia & New Zealand
  • 15.8.5. Rest of Asia Pacific
• 15.9. Market Attractiveness Analysis
  • 15.9.1. By Technology
  • 15.9.2. By Material
  • 15.9.3. By Stent Design
  • 15.9.4. By Placement of Stent
  • 15.9.5. By Indication
  • 15.9.6. By End-user
  • 15.9.7. By Country / Sub-region

16. Latin America Venous Stents Market Analysis and Forecast

• 16.1. Introduction
  • 16.1.1. Key Findings
• 16.2. Market Value Forecast By Technology, 2020-2034
  • 16.2.1. Iliac Vein Stent Technology
  • 16.2.2. Wallstent Technology
  • 16.2.3. Others
• 16.3. Market Value Forecast By Material, 2020-2034
  • 16.3.1. Nitinol
  • 16.3.2. Elgiloy
  • 16.3.3. Stainless Steel
• 16.4. Market Value Forecast By Stent Design, 2020-2034
  • 16.4.1. Braided
  • 16.4.2. Laser-cut
  • 16.4.3. Open-cell
  • 16.4.4. Closed-cell
• 16.5. Market Value Forecast By Placement of Stent, 2020-2034
  • 16.5.1. Lower Limbs
  • 16.5.2. Thorax
  • 16.5.3. Abdomen
  • 16.5.4. Upper Limbs
• 16.6. Market Value Forecast By Indication, 2020-2034
  • 16.6.1. Chronic Deep Vein Thrombosis
  • 16.6.2. Post Thrombotic Syndrome
  • 16.6.3. May-Thurner Syndrome
  • 16.6.4. Nutcracker Syndrome
  • 16.6.5. Hemodialysis / Arteriovenous Fistulae
  • 16.6.6. Others
• 16.7. Market Value Forecast By End-user, 2020-2034
  • 16.7.1. Hospitals
  • 16.7.2. Ambulatory Surgical Centers
  • 16.7.3. Specialty Centers
  • 16.7.4. Others
• 16.8. Market Value Forecast By Country / Sub-region, 2020-2034
  • 16.8.1. Brazil
  • 16.8.2. Mexico
  • 16.8.3. Rest of Latin America
• 16.9. Market Attractiveness Analysis
  • 16.9.1. By Technology
  • 16.9.2. By Material
  • 16.9.3. By Stent Design
  • 16.9.4. By Placement of Stent
  • 16.9.5. By Indication
  • 16.9.6. By End-user
  • 16.9.7. By Country / Sub-region

17. Middle East & Africa Venous Stents Market Analysis and Forecast

• 17.1. Introduction
  • 17.1.1. Key Findings
• 17.2. Market Value Forecast By Technology, 2020-2034
  • 17.2.1. Iliac Vein Stent Technology
  • 17.2.2. Wallstent Technology
  • 17.2.3. Others
• 17.3. Market Value Forecast By Material, 2020-2034
  • 17.3.1. Nitinol
  • 17.3.2. Elgiloy
  • 17.3.3. Stainless Steel
• 17.4. Market Value Forecast By Stent Design, 2020-2034
  • 17.4.1. Braided
  • 17.4.2. Laser-cut
  • 17.4.3. Open-cell
  • 17.4.4. Closed-cell
• 17.5. Market Value Forecast By Placement of Stent, 2020-2034
  • 17.5.1. Lower Limbs
  • 17.5.2. Thorax
  • 17.5.3. Abdomen
  • 17.5.4. Upper Limbs
• 17.6. Market Value Forecast By Indication, 2020-2034
  • 17.6.1. Chronic Deep Vein Thrombosis
  • 17.6.2. Post Thrombotic Syndrome
  • 17.6.3. May-Thurner Syndrome
  • 17.6.4. Nutcracker Syndrome
  • 17.6.5. Hemodialysis / Arteriovenous Fistulae
  • 17.6.6. Others
• 17.7. Market Value Forecast By End-user, 2020-2034
  • 17.7.1. Hospitals
  • 17.7.2. Ambulatory Surgical Centers
  • 17.7.3. Specialty Centers
  • 17.7.4. Others
• 17.8. Market Value Forecast By Country / Sub-region, 2020-2034
  • 17.8.1. GCC Countries
  • 17.8.2. South Africa
  • 17.8.3. Rest of Middle East & Africa
• 17.9. Market Attractiveness Analysis
  • 17.9.1. By Technology
  • 17.9.2. By Material
  • 17.9.3. By Stent Design
  • 17.9.4. By Placement of Stent
  • 17.9.5. By Indication
  • 17.9.6. By End-user
  • 17.9.7. By Country / Sub-region

18. Competition Landscape

• 18.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 18.2. Company Profiles
  • 18.2.1. Becton, Dickinson, and Company (BD)
    • 18.2.1.1. Company Overview
    • 18.2.1.2. Financial Overview
    • 18.2.1.3. Product Portfolio
    • 18.2.1.4. Business Strategies
    • 18.2.1.5. Recent Developments
  • 18.2.2. Medtronic plc
    • 18.2.2.1. Company Overview
    • 18.2.2.2. Financial Overview
    • 18.2.2.3. Product Portfolio
    • 18.2.2.4. Business Strategies
    • 18.2.2.5. Recent Developments
  • 18.2.3. Boston Scientific Corporation
    • 18.2.3.1. Company Overview
    • 18.2.3.2. Financial Overview
    • 18.2.3.3. Product Portfolio
    • 18.2.3.4. Business Strategies
    • 18.2.3.5. Recent Developments
  • 18.2.4. Cook Medical
    • 18.2.4.1. Company Overview
    • 18.2.4.2. Financial Overview
    • 18.2.4.3. Product Portfolio
    • 18.2.4.4. Business Strategies
    • 18.2.4.5. Recent Developments
  • 18.2.5. Koninklijke Philips N.V.
    • 18.2.5.1. Company Overview
    • 18.2.5.2. Financial Overview
    • 18.2.5.3. Product Portfolio
    • 18.2.5.4. Business Strategies
    • 18.2.5.5. Recent Developments
  • 18.2.6. Bentley InnoMed GmbH
    • 18.2.6.1. Company Overview
    • 18.2.6.2. Financial Overview
    • 18.2.6.3. Product Portfolio
    • 18.2.6.4. Business Strategies
    • 18.2.6.5. Recent Developments
  • 18.2.7. W. L. Gore & Associates, Inc.
    • 18.2.7.1. Company Overview
    • 18.2.7.2. Financial Overview
    • 18.2.7.3. Product Portfolio
    • 18.2.7.4. Business Strategies
    • 18.2.7.5. Recent Developments
  • 18.2.8. optimed Medizinische Instrumente GmbH
    • 18.2.8.1. Company Overview
    • 18.2.8.2. Financial Overview
    • 18.2.8.3. Product Portfolio
    • 18.2.8.4. Business Strategies
    • 18.2.8.5. Recent Developments
  • 18.2.9. plus medica GmbH & Co. KG
    • 18.2.9.1. Company Overview
    • 18.2.9.2. Financial Overview
    • 18.2.9.3. Product Portfolio
    • 18.2.9.4. Business Strategies
    • 18.2.9.5. Recent Developments
  • 18.2.10. SUZHOU INNOMED MEDICAL DEVICE CO.,LTD
    • 18.2.10.1. Company Overview
    • 18.2.10.2. Financial Overview
    • 18.2.10.3. Product Portfolio
    • 18.2.10.4. Business Strategies
    • 18.2.10.5. Recent Developments